Education
Healthcare Professional Blog

Education Library

 

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Learn More Watch Interview

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Filter

Filter Results

Condition

Audience

Topic

Type

Calculating Total Heparin Rate

Calculating Total Heparin Rate

Learn how to account for Impella® delivered heparin when calculating the total heparin dose for a patient supported with an Impella heart pump. 

Automated Impella® Controller (AIC): Understanding and Navigating the Placement Screen

Automated Impella® Controller (AIC): Understanding and Navigating the Placement Screen

Jo Kajewski, global Impella® trainer, describes the soft buttons, waveforms, and other information displayed on the AIC placement screen when a patient is on Impella support. 

Impella® Skills Video: Changing the Femoral Access Site Dressing in the ICU

Impella® Skills Video: Changing the Femoral Access Site Dressing in the ICU

This Impella skills video demonstrates how to change the femoral access site dressing in the ICU.

Impella® Skills Video: Adjusting the LV Placement Signal

Impella® Skills Video: Adjusting the LV Placement Signal

This Impella skills video demonstrates how to adjust the LV placement signal for the Impella CP® with SmartAssist® and Impella 5.5® with SmartAssist®.

Dr. Babar Basir, DO: CERAMICS Trial

Dr. Babar Basir, DO: CERAMICS Trial

Babar Basir, DO, discusses CERAMICS, a trial designed to be a next step to NCSI.

Dr. Babar Basir: Importance of Timing to MCS Implant in Cardiogenic Shock

Dr. Babar Basir: Importance of Timing to MCS Implant in Cardiogenic Shock

Dr. Babar Basir, DO, discusses the importance of the timing to MCS implant for outcomes in patients with cardiogenic shock.

Dr. Babar Basir: Identifying Patients with AMICS

Dr. Babar Basir: Identifying Patients with AMICS

Dr. Babar Basir, DO, briefly explains what was learned about identifying patients with AMI cardiogenic shock in the National Cardiogenic Shock Initiative (NCSI) study.

Dr. Babar Basir: NCSI Best Practices

Dr. Babar Basir: NCSI Best Practices

Dr. Babar Basir, DO, describes the best practices from the National Cardiogenic Shock Initiative (NCSI) study.

Dr. Babar Basir: NCSI Study Overview and Objectives

Dr. Babar Basir: NCSI Study Overview and Objectives

Babar Basir discusses overview and objectives of the NCSI study

Dr. Babar Basir: Importance of Door-To-Support in Cardiogenic Shock

Dr. Babar Basir: Importance of Door-To-Support in Cardiogenic Shock

Dr. Babar Basir, DO, discusses the evolving understanding of the importance of unloading with Impella® Heart Pump in patients with cardiogenic shock. 

Dr. Babar Basir: Best Practices and Opportunities From NCSI

Dr. Babar Basir: Best Practices and Opportunities From NCSI

Dr. Babar Basir, DO, discusses the best practices identified from the National Cardiogenic Shock Initiative (NCSI) study and the opportunities for improving outcomes.

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

A Decade of Progress in Cardiogenic Shock Treatment: DanGer Shock RCT, a Milestone in Cardiogenic Shock Trials

A Decade of Progress in Cardiogenic Shock Treatment: DanGer Shock RCT, a Milestone in Cardiogenic Shock Trials

Mir B. Basir, DO, discusses the impact of the DanGer Shock RCT in clinical practice, and looks into the future of AMI cardiogenic shock treatment and management.

Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock

The NCSI (National Cardiogenic Shock Initiative) assessed the feasibility of using a shock protocol and in-hospital survival in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS).

Results from the IMPELLA-PL Registry in Poland

Results from the IMPELLA-PL Registry in Poland

Arkadiusz Pietrasik, MD, PhD, and Aleksandra Gąsecka, MD, PhD discuss their recently published findings from the IMPELLA-PL registry in Poland.

Subscribe for Our Healthcare Professional Newsletter

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.

Subscribe Now
CAMP PCI™

A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.

Request Account

Downloads

Discover further resources like brochures, data sheets and indications for use.

NPS-891

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].

The Protected PCI community
is now on HeartRecovery.com

Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
Explore Now